ClinicalTrials.gg
CompletedNCT02325947iMoveUpdated Sep 29, 2017

Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients

An interventional study of hand exoskeleton, brain-computer interface (BCI), and hand exoskeleton, sham BCI in Poststroke/CVA Paresis, sponsored by Russian Academy of Medical Sciences. Completed at 1 site in Russia. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-09-29.

Sponsored by Russian Academy of Medical Sciences · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to assess the efficacy of non-invasive BCI-exoskeleton technology based on EEG patterns recognition matching to motor imagery in post-stroke patients with hand paresis.

Read the detailed description

The BCI training is based on EEG activity patterns recording during hand motor imagery. A subject sit comfortably 1m from a computer screen which presents visual instructions during the session. The robotic exoskeleton is fixed to the paretic hand. Subject visually fixate on a circle presented in the center of the screen and receive instructions from three surrounding rhomboidal arrows. Subject is given three commands instructing them to relax or imagine slow hand opening movement with the right or left hand. The "Relax" command means that the subject have to sit still and look at the center of the screen. Commands are presented randomly, each of 10 sec duration.

A visual cue provides the subject with feedback regarding the mental task recognition: the central circle turned green if the classifier recognizes the task in agreement with the given command, or remains white if the signal is not recognized. In addition to visual feedback the subject is provided with kinesthetic feedback: the exoskeleton is opening the hand when the classifier recognizes the imagery of paretic hand movement.

The EEG is registered with 30 electrodes distributed over the head in accordance with the standard international 10-20 system. EEG signals are filtered from 5-30Hz. A Bayesian approach for EEG pattern classifying is used in the system. The activity sources most relevant for BCI functioning will be identified using an independent component analysis (ICA). Classification accuracy will by measured with Cohen's kappa (Kohavi and Provost, 1998). The procedure may consist from up to three sessions, the duration of 1 session is 10 min, there are 5 min time brake between session and total duration of procedure is up to 45 min. The number of procedures - at least 10. The maximal interval between procedures is 3 days.

02

Conditions studied

  • Poststroke/CVA Paresis

Keywords

  • Post stroke hand paresis brain injury
03

In context

Lead sponsor

Russian Academy of Medical Sciences is the lead sponsor of 35 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed informed consent
  • Medical history of primary acute cerebrovascular event (ischemic or hemorrhagic stroke) at least 4 weeks before screening
  • focal stroke located in a hemisphere
  • post stroke hand paresis (mild to plegia according to Medical Research Council (MRC) Scale for Muscle Strength)

Exclusion criteria

Exclusion Criteria:

  • Montreal Cognitive Assessment (MoCA) scale \< 22
  • Left handedness
  • Sensory aphasia
  • Severe impairment of vision
  • Modified Ashworth Scale (MAS) ≥ 4
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    Study group

    Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes

    Device: hand exoskeleton, brain-computer interface (BCI),

  • Sham comparator
    Placebo group

    Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)

    Device: hand exoskeleton, sham BCI

Interventions

  • Devicehand exoskeleton, brain-computer interface (BCI),

    Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes

    Also known as: mind-machine interface

  • Devicehand exoskeleton, sham BCI

    Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)

06

What researchers measure

Primary outcomes

  1. Change from Baseline in hand paresis level and hand muscle spasticity

    ARAT; Fugl-Meyer, Modified Ashworth scale

    Time frame: Week 2

Secondary outcomes

  1. Long-term changes from Baseline in hand paresis level and hand muscle spasticity

    ARAT; Fugl-Meyer, Modified Ashworth scale

    Time frame: week 4, week 12, week 24

07

Study locations

1 site
  • Research Center of Neurology of RAMS
    Moscow, 125367, Russia
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2015, a primary completion of Sep 2017 and a completion of Sep 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2014
First posted
Dec 25, 2014
Start
Jan 2015
Primary completionActual
Sep 2017
CompletionActual
Sep 2017
Last update
Sep 29, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 29, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02325947
Lead sponsor
Russian Academy of Medical Sciences
Collaborators
Pirogov Russian National Research Medical University
Responsible party
Roman Lyukmanov (Research scientist, Russian Academy of Medical Sciences) — Principal investigator
First posted
Dec 25, 2014
Start date
Jan 2015
Primary completion
Sep 2017
Completion
Sep 2017
Last update
Sep 29, 2017

Study contacts

Roman Lyukmanov, MD
principal investigator · Russian Academy of Medical Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion